Taevas
United Arab EmiratesFood & Dietary Supplements
Product Registration
Market Access for Product-Registration in United Arab Emirates
Navigating the complexities of global market entry requires a robust strategy. Taevas Life Sciences provides comprehensive market access solutions, ensuring your product achieves optimal positioning and reimbursement across diverse international markets p
Market
Global
Industry
Product-Registration
Regulator
Diverse National Regulatory Bodies
Timeline
8-12 weeks (Strategy Development)
Deliverables
Market Access Strategy, HTA Dossier Support, Pricing Models
What We Deliver
6 Pillars of Global Market Access for Product Registration
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory Intelligence
Thorough analysis of national and regional regulatory landscapes to identify requirements, challenges, and opportunities for product registration and market access.
Country-specific regulatory pathway mapping
Anticipating policy changes and their impact
How It Works
Our Global Market Access Strategy Development Process
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Discovery & Landscape Analysis
We begin by thoroughly understanding your product's profile, clinical data, and target markets. This includes an in-depth analysis of global regulatory, HTA, and payer landscapes.
Market Snapshot
Market Overview: Global Product Registration & Market Access Landscape
Increasing Regulatory Divergence
The global landscape is characterized by increasingly divergent regulatory and HTA requirements across countries, demanding highly localized and adaptive market access strategies.
Value-Based Healthcare Imperative
Payers globally are shifting towards value-based decision-making, emphasizing real-world evidence and demonstrable patient outcomes, making robust value dossiers critical for market access.
Digital Transformation in Access
Leveraging digital tools for evidence generation, stakeholder communication, and market intelligence is becoming paramount for efficient and effective global market access strategies.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Comprehensive Global Market Access Strategy Document
A detailed report outlining strategic pathways, key considerations, and actionable recommendations for market entry and reimbursement across target geographies.
Health Technology Assessment (HTA) Readiness Report
An assessment of your product's HTA preparedness, including gap analysis and recommendations for evidence generation to meet specific HTA body requirements.
Global Pricing & Reimbursement Landscape Analysis
An in-depth report on pricing benchmarks, reimbursement policies, and potential revenue forecasts across selected global markets.
Stakeholder Engagement & Communication Plan
A strategic plan identifying key influencers and payers, with tailored messaging and engagement tactics to build advocacy and support.
Who This Is For
Use Cases
Biotech Launch
Accelerating Orphan Drug Market Entry in EU & APAC
A biotech company with a novel orphan drug needed to navigate complex HTA processes and achieve premium pricing across multiple EU and APAC countries simultaneously.
Outcome
Taevas developed a harmonized global value dossier and country-specific pricing strategies, securing favorable reimbursement in 8 key markets within 18 months.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Secure Global Market Access for Your Product?
Partner with Taevas Life Sciences to transform your product registration into successful market entry. Our expert team is ready to guide you through every stage of the market access journey, ensuring optimal patient access and commercial success.
Expert Global Insights
Tailored Strategic Roadmaps
Accelerated Market Entry
Optimized Reimbursement Outcomes